HC
ELV icon

Henshaw Capital’s Elevance Health ELV Stock Holding History

Henshaw Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-687
Closed -$312K – 272
2022
Q3 		$312K Sell
687
-82
-11% -$39.2K 0.02% 197
2022
Q2 		$371K Buy
769
+121
+19% +$59.9K 0.03% 178
2022
Q1 		$318K Buy
+648
New +$296K 0.02% 237
2021
Q3 		– Sell
-651
Closed -$249K – 336
2021
Q2 		$249K Hold
651
– – 0.02% 315
2021
Q1 		$234K Buy
+651
New +$209K 0.02% 315

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Henshaw Capital's ELV Position: Q4 2022 in Review

Henshaw Capital sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 687 shares — an estimated $312K sold.

Henshaw Capital first reported a position in ELV in Q1 2021 and held it in 5 quarters. The position peaked at $371K in Q2 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Henshaw Capital reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • Henshaw Capital sold 687 Elevance Health shares in Q4 2022, an estimated $312K.
  • Henshaw Capital first reported a position in Elevance Health in Q1 2021 and held it in 5 quarters.
  • Henshaw Capital's Elevance Health position peaked at $371K in Q2 2022.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Henshaw Capital's 13F filing for Q4 2022, filed 28 May 2026.